Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 18;15(22):4829.
doi: 10.3390/nu15224829.

Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics

Affiliations
Review

Dietary and Nutritional Interventions in Nonalcoholic Fatty Liver Disease in Pediatrics

Camila Farías et al. Nutrients. .

Abstract

Nonalcoholic fatty liver disease (NAFLD) is pediatrics' most common chronic liver disease. The incidence is high in children and adolescents with obesity, which is associated with an increased risk of disease progression. Currently, there is no effective drug therapy in pediatrics; therefore, lifestyle interventions remain the first line of treatment. This review aims to present an updated compilation of the scientific evidence for treating this pathology, including lifestyle modifications, such as exercise and dietary changes, highlighting specific nutritional strategies. The bibliographic review was carried out in different databases, including studies within the pediatric population where dietary and/or nutritional interventions were used to treat NAFLD. Main interventions include diets low in carbohydrates, free sugars, fructose, and lipids, in addition to healthy eating patterns and possible nutritional interventions with n-3 polyunsaturated fatty acids (EPA and DHA), amino acids (cysteine, L-carnitine), cysteamine, vitamins, and probiotics (one strain or multi-strain). Lifestyle changes remain the main recommendation for children with NAFLD. Nevertheless, more studies are required to elucidate the effectiveness of specific nutrients and bioactive compounds in this population.

Keywords: eating patterns; exercise; pediatric NAFLD; polyunsaturated fatty acids; vitamins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Physio-pathogenesis of non-alcoholic fatty liver disease. IR, insulin resistance; LXR, liver X receptors; SREBP-1C, Sterol-regulatory element binding protein-1C; ChREBP, carbohydrate-responsive element-binding protein, DNL, de novo lipogenesis; NAFLD, Non-alcoholic fatty liver disease, VLDL, very low-density lipoprotein; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase. ↑ Increment.
Figure 2
Figure 2
Interventions in nonalcoholic fatty liver disease in children and adolescents. EPA, Eicosapentaenoic Acid; DHA, Docosahexaenoic acid; WC, waist circumference; IR, insulin resistance; TG, Triglycerides; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; DNL, de novo lipogenesis. ↑ Increment. ↓ reduced.

References

    1. Trandafir L.M., Frasinariu O.E., Leon-Constantin M.M., Chiriac Ş., Trandafirescu M.F., Miron I.C., Luca A.C., Iordache A.C., Cojocaru E. Pediatric nonalcoholic fatty liver disease—A changing diagnostic paradigm. Rom. J. Morphol. Embryol. 2020;61:1023–1031. doi: 10.47162/RJME.61.4.04. - DOI - PMC - PubMed
    1. Anderson E.L., Howe L.D., Jones H.E., Higgins J.P., Lawlor D.A., Fraser A. The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS ONE. 2015;10:e0140908. doi: 10.1371/journal.pone.0140908. - DOI - PMC - PubMed
    1. Li J., Ha A., Rui F., Zou B., Yang H., Xue Q., Hu X., Xu Y., Henry L., Barakat M., et al. Meta-analysis: Global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000–2021. Aliment. Pharmacol. Ther. 2022;56:396–406. doi: 10.1111/apt.17096. - DOI - PubMed
    1. Shaunak M., Byrne C.D., Davis N., Afolabi P., Faust S.N., Davies J.H. Non-alcoholic fatty liver disease and childhood obesity. Arch. Dis. Child. 2021;106:3–8. doi: 10.1136/archdischild-2019-318063. - DOI - PubMed
    1. Sun Y., Tan Z., Jiang Z., Li M., Wang W., Huang Y., Sun J. Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescence: A protocol for a Bayesian network meta analysis. Medicine. 2021;100:e24277. doi: 10.1097/MD.0000000000024277. - DOI - PMC - PubMed